Clinical Trial Update: Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 open-label study of donepezil in vascular dementia and mixed dementia was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dementia
• Vascular Dementia

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Pfizer | Conditions: Dementia, Vascular, Dementia, Mixed | Phase 3 | Status: TERMINATED | Results posted: 2009-06-12